Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
Crossref DOI link: https://doi.org/10.1007/s10620-017-4729-1
Published Online: 2017-09-07
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pimentel, M.
Cash, B. D.
Lembo, A.
Wolf, R. A.
Israel, R. J.
Schoenfeld, P.
License valid from 2017-09-07